[1]刘璐,田耘.IgA肾病的现代中西医治疗研究进展[J].西部中医药,2023,36(10):161-166.[doi:10.12174/j.issn.2096-9600.2023.10.35]
　LIU Lu,TIAN Yun.Research Progress in Modern Chinese and Western Medicine Treatment of IgA Nephropathy[J].Western Journal of Traditional Chinese Medicine,2023,36(10):161-166.[doi:10.12174/j.issn.2096-9600.2023.10.35]
点击复制

IgA肾病的现代中西医治疗研究进展
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
36
期数:
2023年10期
页码:
161-166
栏目:
出版日期:
2023-10-15

文章信息/Info

Title:
Research Progress in Modern Chinese and Western Medicine Treatment of IgA Nephropathy
作者:
刘璐1,2, 田耘2
1.陕西中医药大学第一临床医学院，陕西 咸阳 712046
2.陕西省中医医院，陕西 西安 710003
Author(s):
LIU Lu1,2, TIAN Yun2
1.The First Clinical Medical College of Shaanxi University of Chinese Medicine, Xianyang 712046, China
2.Shaanxi Hospital of Traditional Chinese Medicine, Xi'an 710003, China
关键词:
IgA肾病; 原发性肾小球肾炎; 西医治疗; 中医治疗
Keywords:
IgA nephropathy; primary glomerular nephritis; Western medicine therapy; TCM therapy
分类号:
R692.6
DOI:
10.12174/j.issn.2096-9600.2023.10.35
文献标志码:
A
摘要:
从IgA肾病的中、西医治疗两方面进行论述，认为IgA肾病是我国目前最常见的原发性肾小球疾病之一。其特征是IgA为主的免疫复合物沉积在肾小球系膜区，其临床表现多样。西医治疗主要以糖皮质激素和免疫抑制剂为主，中医药治疗是在个体化基础上进行辨证施治并结合个人经验，两者互有长短。
Abstract:
By stating the Chinese medicine therapy and Western medicine therapy of IgA nephropathy, IgA nephropathy (IgAN) is one of the most common primary glomerular diseases in China, characterized by the deposition of IgA-based immune complexes in the glomerular mesangial area, with diversified clinical mani-festations. Western medicine treatment is mainly on glucocorticoids and immunosuppressive agents, and TCM therapy is individualized therapy based on syndrome differentiation and treatment combined with individual experience, both have their own strengthens and weaknesses.

相似文献/References:

[1]孟伟,姜健,沈沛成△,等.益气固本调免方对IgA肾病患者外周血TGF-β１表达的影响[J].西部中医药,2018,31(04):1.
　MENG Wei,JIANG Jian,SHEN Peicheng,et al.Effects of YiQi GuBen TiaoMian Prescription on the Expression of TGF-β１in Peripheral Blood of the Patients with IgA Nephropathy[J].Western Journal of Traditional Chinese Medicine,2018,31(10):1.
[2]张芮,林燕.曹式丽教授从外感辨治IgA肾病经验[J].西部中医药,2021,34(02):52.[doi:10.12174/j.issn.2096-9600.2021.02.13]
　ZHANG Rui,LIN Yan.On Professor Cao Shili′s Experience in Differentiating and Treating IgA Nephropathy from Exogenous Pathogen[J].Western Journal of Traditional Chinese Medicine,2021,34(10):52.[doi:10.12174/j.issn.2096-9600.2021.02.13]
[3]庞欣欣,王学艺,朱清,等.中药栀子治疗IgA肾病的网络药理学研究[J].西部中医药,2023,36(06):61.[doi:10.12174/j.issn.2096-9600.2023.06.14]
　PANG Xinxin,WANG Xueyi,ZHU Qing,et al.Network Pharmacology-based Study on Treating IgA Nephropathy with Zhizi[J].Western Journal of Traditional Chinese Medicine,2023,36(10):61.[doi:10.12174/j.issn.2096-9600.2023.06.14]
[4]郑明余,田园.基于TLR4/NF-κB信号通路探讨大黄酸对IgA肾病模型大鼠的影响[J].西部中医药,2024,37(08):15.[doi:10.12174/j.issn.2096-9600.2024.08.04]
　ZHENG Mingyu,TIAN Yuan.Study on the Effect of Rhein on IgA Nephropathy Rat Models via TLR4/NF-κB Signaling Pathway[J].Western Journal of Traditional Chinese Medicine,2024,37(10):15.[doi:10.12174/j.issn.2096-9600.2024.08.04]

备注/Memo

备注/Memo:
刘璐（1996—），女，硕士学位，医师。研究方向：肾病的基础与临床研究。国家自然科学基金（81774123），陕西省重点研发计划项目（2018ZDXM-SF-011）。
更新日期/Last Update: 1900-01-01